Drug-induced and iatrogenic infiltrative lung disease

Clinics in Chest Medicine

Volumn 25, Issue 3, 2004, Pages 479-519

  Camus, Philippe ^a   Bonniaud, Philippe ^a   Fanton, Annlyse ^a   Camus, Clio ^a   Baudaun, Nicolas ^a   Foucher, Pascal ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABCIXIMAB; ACEBUTOLOL; ACETYLSALICYLIC ACID; ACICLOVIR; ADRENALIN; ALBUMIN; ALLOCHRYSINE; ALLOPURINOL; AMINOGLUTETHIMIDE; AMIODARONE; AMITRIPTYLINE; AMPHOTERICIN B; AMPICILLIN; AMRINONE; ANAGRELIDE; ANTAZOLINE; ATENOLOL; AZAPROPAZONE; BARBITURIC ACID DERIVATIVE; BCG VACCINE; BECLOMETASONE; BEPRIDIL; BETAXOLOL; BICALUTAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETRETIN; PARACETAMOL; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ANAPHYLAXIS; BRONCHIOLITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CROSS REACTION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DYSPNEA; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; LOEFFLER PNEUMONIA; LUNG CIRCULATION; LUNG EDEMA; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TOXICITY; LUPUS ERYTHEMATOSUS; LYMPH NODE; MEDIASTINUM; PLEURA CAVITY; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SARCOIDOSIS; THORAX PAIN;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DRUG THERAPY; HUMANS; IATROGENIC DISEASE; LUNG DISEASES; METHOTREXATE; PNEUMONIA; PULMONARY ALVEOLI; PULMONARY EDEMA; SARCOIDOSIS, PULMONARY;

EID: 4344581106     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.05.006     Document Type: Review

References (88)

1. Wolff A.J., O'Donnell A.E. Pulmonary effects of illicit drug use. Clin Chest Med. 25:2004;203-216
2. Pneumotox® website. Available at: http://www.pneumotox.com. Last update: April, 2004
3. Camus P., Foucher P., Bonniaud P., Ask K. Drug-induced infiltrative lung disease. Eur Respir J. 32:2001;93s-100s
4. Flieder D.B., Travis W.D. Pathologic characteristics of drug-induced lung disease. Clin Chest Med. 25:2004;37-46
5. Camus P., Martin W.J. II, Rosenow E.C. III Amiodarone pulmonary toxicity. Clin Chest Med. 25:2004;65-76
6. White D.A. Drug-induced pulmonary infection. Clin Chest Med. 25:2004;179-188
7. Kremer J.M., Alarcon G.S., Weinblatt M.E., Kaymakcian M.V., Macaluso M., Cannon G.W., et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. Arthritis Rheum. 40:1997;1829-1837
8. Camus P. Drug-induced infiltrative lung diseases. Schwarz M.I., King T.E. Jr. Infiltrative lung diseases. 4th edition:2003;485-534 B C Dekker, Inc., Hamilton (Ontario)
9. Camus P. Drug history and remote exposure to drugs. A cause of lung disease? Eur Respir J. 16:2000;381-384
10. Pirmohamed M., Naisbitt D.J., Gordon F., Park B.K. The danger hypothesis - potential role in idiosyncratic drug reactions. Toxicology. 181-2:2002;55-63
11. Cleverley J.R., Screaton N.J., Hiorns M.P., Flint J.D., Müller N.L. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 57:2002;292-299
12. Abratt R.P., Onc F.R., Morgan G.W., Silvestri G., Willcox P. Pulmonary complications of radiation therapy. Clin Chest Med. 25:2004;167-177
13. Lee-Chiong T.L.J., Matthay R.A. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med. 25:2004;95-104
14. Kopko P.M., Holland P.V. Transfusion-related lung injury. Br J Haematol. 105:1999;322-329
15. Logan P.M., Primack S.L., Staples C., Miller R.R., Müller N.L. Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph. Chest. 108:1995;1283-1287
16. Zisman D.A., McCune W.J., Tino G., Lynch J.P.I. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis. 18:2001;243-252
17. Lock B.J., Eggert M., Cooper J.A.D. Jr. Infiltrative lung disease due to noncytotoxic agents. Clin Chest Med. 25:2004;47-52
18. Cannon G.W. Methotrexate pulmonary toxicity. Rheum Dis Clin North Am. 23:1997;917-937
19. Verra F., Hmouda H., Rauss A., Lebargy F., Cordonnier C., Bignon J., et al. Bronchoalveolar lavage in immunocompromised patients. Clinical and functional consequences. Chest. 101:1992;1215-1220
20. Fuhrman C., Parrot A., Wislez M., Prigent H., Boussaud V., Bernaudin J.F., et al. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am J Respir Crit Care Med. 164:2001;1186-1191
21. 4 cell count may predict this complication. Respir Med. 87:1993;153-155
22. Clearkin R., Corris P.A., Thomas S.H.L. Methotrexate pneumonitis in a patient with rheumatoid arthritis. Postgr Med J. 73:1997;603-604
23. Imokawa S., Colby T.V., Leslie K.O., Helmers R.A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J. 15:2000;373-381
24. Limper A.H. Chemotherapy-induced lung disease. Clin Chest Med. 25:2004;53-64
25. Costabel U., Uzaslan E., Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med. 25:2004;25-36
26. Donaldson L., Grant I.S., Naysmith M.R., Thomas J.S. Acute amiodarone-induced lung toxicity. Intensive Care Med. 24:1998;626-630
27. Liverani E., Armuzzi A., Mormile F., Anti M., Gasbarrini G., Gentiloni N. Amiodarone-induced adult respiratory distress syndrome after nonthoracotomy subcutaneous defibrillator implantation. J Intern Med. 249:2001;565-566
28. van Mieghem W., Coolen L., Malysse I., Lacquet L.M., Deneffe G.J.D., Demedts M.G.P. Amiodarone and the development of ARDS after lung surgery. Chest. 105:1994;1642-1645
29. Rady M.Y., Ryan T., Starr N.J. Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery. Anesth Analg. 85:1997;489-497
30. Gehlbach B.K., Geppert E. The pulmonary manifestations of left heart failure. Chest. 125:2004;669-682
31. Bristedt P., Tylén U. Pulmonary edema following intravenous injection of nonionic low-osmolar contrast medium - Appearance on HRCT - A case report. Acta Radiol. 39:1998;81-83
32. Kopko P.M., Popovsky M.A. Pulmonary injury from transfusion-related acute lung injury. Clin Chest Med. 25:2004;105-113
33. Schwarz M.I., Fontenot A.P. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med. 25:2004;133-140
34. Freemer M.M., King T.E. Jr. Connective tissue diseases. Schwarz M.I., King T.E. Jr. Infiltrative lung diseases. 4th edition:2003;535-598 B C Dekker, Inc., Hamilton (Ontario)
35. Choi H.K., Merkel P.A., Walker A.M., Niles J.L. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 43:2000;405-413
36. Fontenot A.P., Schwarz M.I. Diffuse alveolar hemorrhage. Schwarz M.I., King T.E. Jr. Infiltrative lung diseases. 4th edition:2003;632-656 B C Dekker, Inc., Hamilton (Ontario)
37. Choi H.K., Merkel P.A., Cohen-Tervaert J.W., Black R.M., McCluskey R.T., Niles J.L. Alternating antineutrophil cytoplasmic antibody specificity. Drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum. 42:1999;384-388
38. Cohen A.J., King T.E. Jr., Downey G.P. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 149:1994;1670-1675
39. Epler G.R. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med. 25:2004;89-94
40. Beasley M.B., Franks T.J., Galvin J.R., Gochuico B., Travis W.D. Acute fibrinous and organizing pneumonia. A histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med. 126:2002;1064-1070
41. Nizami I.Y., Kissner D.G., Vissher D.W., Dubaybo B.A. Idiopathic bronchiolitis obliterans with organizing pneumonia. An acute and life-threatening syndrome. Chest. 108:1995;271-277
42. Pfitzenmeyer P., Foucher P., Piard F., Coudert B., Braud M.L., Gabez P., et al. Nilutamide pneumonitis: a report on eight patients. Thorax. 47:1992;622-627
43. Akira M., Ishikawa H., Yamamoto S. Drug-induced pneumonitis: thin-section CT findings in 60 patients. Radiology. 224:2002;852-860
44. Bone R.C., Wolfe J., Sobonya R.E., Kerby G.R., Stechschulte D., Ruth W.E., et al. Desquamative interstitial pneumonia following long-term nitrofurantoin therapy. Am J Med. 60:1976;697-701
45. Allen J.N. Drug-induced eosinophilic lung disease. Clin Chest Med. 25:2004;77-88
46. Pfitzenmeyer P., Meier M., Zuck P., Peiffer G., Masson P., Turcu A., et al. Piroxicam-induced pulmonary infiltrates and eosinophilia. J Rheumatol. 21:1994;1573-1577
47. Cottin V., Frognier R., Monnot H., Levy A., De Vuyst P., Cordier J.F. Chronic eosinophilic pneumonia after radiation therapy for breast cancer. Eur Respir J. 23:2004;9-13
48. Sitbon O., Bidel N., Dussopt C., Azarian R., Braud M.L., Lebargy F., et al. Minocycline pneumonitis and eosinophilia: a report on 8 patients. Arch Intern Med. 154:1994;1633-1640
49. Camus P. Drug-induced pleural disease. Bouros D., Lenfant C. Pleural disorders. 2004;317-352 M Dekker, New York
50. Camus P., Piard F., Ashcroft T., Gal A.A., Colby T.V. The lung in inflammatory bowel disease. Medicine (Baltimore). 72:1993;151-183
51. Sunderji R., Kanji Z., Gin K. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance. Can J Cardiol. 16:2000;1435-1440
52. Stelfox H.T., Ahmed S.B., Fiskio J., Bates D.W. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther. 75:2004;110-122
53. Malhorta A., Muse V.V., Mark E.J. An 82-year-old man with dyspnea and pulmonary abnormalities. Case Records of the Massachusetts General Hospital - Case 12-2003. N Engl J Med. 348:2003;1574-1585
54. Vernhet H., Bousquet C., Durand G., Giron J., Senac J.P. Reversible amiodarone-induced lung disease: HRCT findings. Eur Radiol. 11:2001;1697-1703
55. Erasmus J.J., McAdams H.P., Rossi S.E. High-resolution CT of drug-induced lung disease. Radiol Clin North Am. 40:2002;61-72
56. Ott M.C., Khoor A., Leventhal J.P., Paterick T.E., Burger C.D. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest. 123:2003;646-651
57. Rossi S.E., Erasmus J.J., McAdams P., Sporn T.A., Goodman P.C. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 5:2000;1245-1259
58. Siniakowicz R.M., Narula D., Suster B., Steinberg J.S. Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol. 12:2001;431-436
59. Chouri N., Langin T., Lantuejoul S., Coulomb M., Brambilla C. Pulmonary nodules with the CT halo sign. Respiration (Herrlisheim). 69:2002;103-106
60. Coudert B., Bailly F., André F., Lombard J.N., Camus P. Amiodarone pneumonitis: bronchoalveolar lavage findings in 15 patients and review of the literature. Chest. 102:1992;1005-1012
61. Bedrossian C.W., Warren C.J., Ohar J., Bhan R. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry. Ann Diagn Pathol. 1:1997;47-56
62. Ryu J.H., Myers J., Swenson S.J. Bronchiolar disorders. Am J Respir Crit Care Med. 168:2003;1277-1292
63. Weyl Ben Arush M., Roguin A., Zamir E., Et-Hassid R., Pries D., Gaitini D., et al. Bleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer. Pediatr Hematol Oncol. 14:1997;381-386
64. Camus P., Lombard J.N., Perrichon M., Guerin J.C., Bejui-Thivolet F., Piard F., et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax. 44:1989;711-715
65. Cameron R.J., Kolbe J., Wilsher M.L., Lambie N. Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin. Thorax. 55:2000;249-251
66. O'Driscoll B.R., Hasleton P.S., Taylor P.M., Poulter L.W., Gattamaneni H.R., Woodcock A.A. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med. 323:1990;378-382
67. O'Driscoll B.R., Kalra S., Gattamaneni H.R., Woodcock A.A. Late carmustine lung fibrosis. Age at treatment may influence severity and survival. Chest. 107:1995;1355-1357
68. Malik S.W., Myers J.L., DeRemee R.A., Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med. 154:1996;1851-1856
69. Tucker A.S., Newman A.J., Alvorado C. Pulmonary, pleural and thoracic changes complicating chemotherapy. Radiology. 125:1977;805-899
70. Lin M. Radiation pneumonitis caused by Yttrium-90 microspheres: radiologic findings. Am J Roentgenol. 162:1994;1300-1322
71. Fourme T., Vieillard-Baron A., Loubières Y., Julie C., Page B., Jardin F. Early fat embolism after liposuction. Anesthesiology. 89:1998;782-784
72. Lekka M.E., Liokatis S., Nathanail C., Galani V., Nakos G. The impact of intravenous fat emulsion administration in acute lung injury. Am J Respir Crit Care Med. 169:2004;638-644
73. Gulbahce H.E., Pambuccian S.E., Jessurun J., Woodard P., Steiner M.E., Manivel J.C., et al. Pulmonary nodular lesions in bone marrow transplant recipients. Impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol. 121:2004;205-210
74. Gondouin A., Manzoni P., Ranfaing E., Brun J., Cadranel J., Sadoun D., et al. Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J. 9:1996;1463-1469
75. Prakash U.B., Rosenow E.C. III Pulmonary complications from ophthalmic preparations. Mayo Clin Proc. 65:1990;521-529
76. Drent M., Cobben N.A.M., Henderson R.F., Jacobs J.A., Wouters E.F.M., van Dieijen-Visser M.P. BAL fluid LDH activity and LDH isoenzyme pattern in lipoid pneumonia caused by an intravenous injection of lamp oil. Eur Respir J. 9:1996;2416-2418
77. Franquet T., Gimenez A., Bordes R., Rodriguez-Arias J.M., Castella J. The crazy-paving pattern in exogenous lipoid pneumonia: CT-pathologic correlation. Am J Roentgenol. 170:1998;315-317
78. Kennedy J.D., Costello P., Balikian J.P., Herman P.G. Exogenous lipoid pneumonia. Am J Roentgenol. 136:1981;1145-1149
79. Tahan V., Ozseker F., Guneylioglu D., Baran A., Ozaras R., Mert A., et al. Sarcoidosis after use of interferon for chronic hepatitis C - report of a case and review of the literature. Dig Dis Sci. 48:2003;169-173
80. de Vriese A.S.P., Philippe J., Van Renterghem D.M., De Cuyper C.A., Hindryckx P.H.F., Matthys E.G.J., et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore). 74:1995;144-150
81. Rademaker M., Maling T. Drug-hypersensitivity syndrome. Available at http://www.medsafe.govt.nz. Accessed April 2004
82. Pichler W.J. Delayed drug hypersensitivity reactions. Ann Intern Med. 139:2003;683-693
83. Camus P. Drug-induced respiratory disease in connective tissue diseases. In: Wells AU, Denton CP, editors. Handbook of systemic autoimmune diseases part VI: pulmonary involvement in systemic autoimmune diseases. In press
84. Adkinson N.F.J., Essayan D., Gruchalla R., Haggerty H., Kawabata T., Sandler J.D., et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol. 109:2002;S461-S478
85. Pfitzenmeyer P., Foucher P., Dennewald G., Chevalon B., Debieuvre D., Bensa P., et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J. 9:1996;1013-1019
86. Bayle J.Y., Nesme P., Bejui-Thivolet F., Loire R., Guérin J.C., Cordier J.F. Migratory organizing pneumonitis "primed" by radiation therapy. Eur Respir J. 8:1995;322-326
87. Crestani B., Kambouchner M., Soler P., Crequit J., Brauner M., Battesti J.P., et al. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J. 8:1995;318-321
88. Stover D.E., Milite F., Zakowski M. A newly recognized syndrome - radiation related bronchiolitis obliterans and organizing pneumonia. Respiration (Herrlisheim). 68:2001;540-544